Origin Therapeutics Holdings (XCNQ:ORIG) Current Deferred Revenue : C$0.00 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Origin Therapeutics Holdings's current deferred revenue for the quarter that ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings Current Deferred Revenue Historical Data

The historical data trend for Origin Therapeutics Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Current Deferred Revenue Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Current Deferred Revenue

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Current Deferred Revenue	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.